Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Study of Investigational Gene-editing Therapies in Participants With or at High Risk for Cardiovascular Disease

NCT06112327 is registered in ClinicalTrials.gov with Verve Therapeutics, Inc. as lead sponsor.

NCT NCT06112327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06112327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Study of Investigational Gene-editing Therapies in Participants With or at High Risk for Cardiovascular Disease
Lead sponsor
Verve Therapeutics, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 9, 2024
Completion date
October 31, 2039
Enrollment
116 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, heterozygous familial hypercholesterolemia, hypercholesterolemia